December 2, 2025 · Form 4 insider transaction
Capps Kathleen S. sold 207 shares of Enanta Pharmaceuticals, Inc. at $13.96 per share, a transaction worth $2.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 27, 2024, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.